| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.756 | 60.000 | 28.104 | 39.617 | 41.141 |
| Total Income - EUR | - | - | - | - | - | 4.756 | 60.239 | 33.340 | 39.617 | 41.141 |
| Total Expenses - EUR | - | - | - | - | - | 26 | 13.694 | 15.625 | 40.854 | 35.929 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 4.729 | 46.545 | 17.715 | -1.237 | 5.212 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.587 | 45.606 | 17.440 | -1.633 | 4.809 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Killintox Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 37 | 688 | 472 | 254 | 36 |
| Current Assets | - | - | - | - | - | 4.734 | 49.964 | 20.946 | 4.910 | 6.203 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 81 | 12.353 | 273 | 221 |
| Cash | - | - | - | - | - | 4.734 | 49.884 | 8.594 | 4.637 | 5.982 |
| Shareholders Funds | - | - | - | - | - | 4.628 | 45.654 | 17.488 | -375 | 4.436 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 143 | 4.998 | 3.930 | 5.538 | 1.803 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8129 - 8129" | |||||||||
| CAEN Financial Year |
8129
|
|||||||||
Comments - Killintox Bio S.r.l.